Emily Largent of the Perelman School of Medicine and colleagues from Stanford University and the University of Denver denounced the FDA’s decisions to delay authorization of the Pfizer-BioNTech vaccine for children younger than 5. “Waiting for third-dose results before opening access will inevitably lead to thousands more children being infected with the coronavirus without the protection of a vaccine,” they wrote.